The current stock price of HTFL is 28.97 USD. In the past month the price increased by 3.46%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 28.36 | 36.08B | ||
| DOCS | DOXIMITY INC-CLASS A | 26.4 | 8.15B | ||
| WAY | WAYSTAR HOLDING CORP | 23.41 | 6.00B | ||
| CERT | CERTARA INC | 17.48 | 1.39B | ||
| SDGR | SCHRODINGER INC | N/A | 1.32B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.25B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 650 | 1.10B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.12B | ||
| PHR | PHREESIA INC | N/A | 976.53M | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 7.86 | 933.43M | ||
| CTEV | CLARITEV CORP | N/A | 560.20M | ||
| HSTM | HEALTHSTREAM INC | 33.51 | 676.18M |
HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The company is headquartered in Mountain View, California and currently employs 699 full-time employees. The company went IPO on 2025-08-08. The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
HEARTFLOW INC
331 E Evelyn Avenue
Mountain View CALIFORNIA US
Employees: 699
Phone: 16502411221
HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The company is headquartered in Mountain View, California and currently employs 699 full-time employees. The company went IPO on 2025-08-08. The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
The current stock price of HTFL is 28.97 USD. The price decreased by -0.62% in the last trading session.
HTFL does not pay a dividend.
HTFL has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
HEARTFLOW INC (HTFL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.75).
HEARTFLOW INC (HTFL) has a market capitalization of 2.47B USD. This makes HTFL a Mid Cap stock.
The outstanding short interest for HEARTFLOW INC (HTFL) is 1.75% of its float.
ChartMill assigns a technical rating of 3 / 10 to HTFL.
ChartMill assigns a fundamental rating of 3 / 10 to HTFL. No worries on liquidiy or solvency for HTFL as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months HTFL reported a non-GAAP Earnings per Share(EPS) of -2.75. The EPS increased by 22.04% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -51.82% | ||
| ROE | -74.17% | ||
| Debt/Equity | 0 |
11 analysts have analysed HTFL and the average price target is 39.37 USD. This implies a price increase of 35.91% is expected in the next year compared to the current price of 28.97.
For the next year, analysts expect an EPS growth of -80.25% and a revenue growth 40.42% for HTFL